Αποτελέσματα Αναζήτησης
12 Σεπ 2023 · We used conventional search methods to identify 1459 publications from 2021 to 2022 using ADNI data/samples and reviewed 291 impactful studies. This review details how ADNI studies improved disease progression understanding and clinical trial efficiency.
1 Ιουλ 2015 · This article reviews the current status of the Clinical Core of the Alzheimer's Disease Neuroimaging Initiative (ADNI), and summarizes planning for the next stage of the project.
31 Δεκ 2021 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing, naturalistic study to understand structural, biochemical, and cognitive changes that occur during Alzheimer's disease (AD) progression.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD).
13 Αυγ 2024 · The central importance of ADNI's clinical classification of participants to pivotal AD trials is clear. In part due to the plethora of papers published on ADNI data, a recent evidence-based medicine review of the literature on MCI performed by the American Academy of Neurology yielded > 11,500 studies on MCI.
Sharing Alzheimer’s research data with the world. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
30 Ιουν 2011 · Clinical data from the ADNI 1, ADNI GO and ADNI 2 phases of the project are now available in the the ADNI Repository (IDA). Once logged in, you may peruse and download assessment, medical history, biospecimen and other data from the DOWNLOAD | Study Data menu. See INSTRUCTIONS for more information.
